Summary
Overview
Work history
Education
Skills
Languages
Certification
Timeline
Generic
Ahmed Ashmawy

Ahmed Ashmawy

Riyadh,Saudi Arabia

Summary

Experienced and results-driven medical affairs professional with over 14 years in the pharmaceutical industry, currently serving as Field Medical Advisor in the field of Cardiometabolic at Novo Nordisk. Proven expertise in developing and executing medical strategies, leading pre-launch & Launch medical plans and engaging key stakeholders to support brand objectives. Strong background in cross-functional collaboration, and scientific communication of stakeholders and training of field teams. Expert at translating complex scientific data into actionable insights and fostering long-term partnerships with healthcare professionals. Known for adaptability, strategic thinking, and a collaborative leadership style in dynamic, fast-paced environments.

Overview

14
14
years of professional experience
1
1
Certification

Work history

Field Medical Advisor - Cardiometabolic

Novo Nordisk Saudi Arabia
Riyadh
06.2025 - Current
  • Led the National medical launch of Wegovy® ( Semaglutide 2.4 mg ) across Saudi Arabia, driving scientific readiness, strategic positioning, and cross functional alignment for the brand
  • Designed and delivered training programs that upskilled the regional medical advisor team on Wegovy's® clinical evidence, and scientific medical communication
  • Spearheaded the implementation and execution of the new Cardiometabolic team structure, optimizing field medical coverage and stakeholder engagement.
  • Partnered cross-functionally with Market access, HEOR, and commercial teams to ensure evidence based messaging and integrated launch execution for obesity and cardiometabolic therapy area.
  • Championed scientific excellence and insight driven strategies that enhanced the field team's capabilities and supported sustainable adoption of Wegovy® in cardiometabolic medical community in Saudi Arabia

Sr. Metabolic Regional Medical Advisor

Novo Nordisk
04.2019 - 05.2025
  • Significantly contributed to the pre-launch medical plan of Semaglutide 2.4 mg in the central region, supporting strategy development, stakeholder engagement, and field team alignment.
  • Led cross functional collaboration between medical, marketing, market access and field force teams to align on pre-launch strategies and ensure successful execution of the strategy in the central region.
  • Mentoring field medical team (RMAs) focusing on disease and product medical knowledge, objection handling, insights generation skills, and strategic communication and management of key stakeholders.
  • Contributed to "All in for Rybelsus" project, supporting strategic medical initiatives and stakeholder alignment to enhance Rybelsus uptake and positioning. Established Saudi Obesity Expert Meeting " SOEM" platform as first local speaker training on obesity management updates.
  • Created medical expansion strategy and launched scientific dialogue to OB/GYN in 2019.
  • Led PSP team during COVID-19 period, helping to conduct 5 webinars for patients and to develop new digital patient educational materials.
  • Drive Saudi Obesity guidelines dissemination plan in different educational activities of Saudi obesity medical team.
  • Assisted in establishing 24 obesity clinics in Saudi Arabia, by providing medical expertise and identifying key partners, in order to enhance obesity management infrastructure at KSA.
  • Leading publication process of ACTION TEENS Saudi Arabia.
  • Spearheaded the first medical insights analysis tool " COMPASS" to enable Obesity business unit to identify HCPs trends and treatment needs.

Sr. Medical Representative

Novo Nordisk
07.2013 - 03.2019
  • Execute the upgrade project in the Saudi military hospitals, the project which resulted in more than 70 % growth in the Sales of modern insulin.
  • Enlisted modern insulin portfolio in the assigned public and private hospitals in the assigned territory.
  • Recognized as the best sales achiever 2017 for exceeding annual sales target by 32%.

Advanced Medical Representative

Novartis Pharmaceuticals
07.2011 - 06.2013

Education

Master of Science - Health Economics

Pompeu De Fabra University

Bachelor of Science - Pharmaceutical Sciences

Helwan University

Skills

  • Medical Affairs Strategy Development
undefined

Languages

Arabic
Native
English
Advanced
Spanish
Beginner

Certification

  • BCMAS "Board Certified Medical Affairs Specialist" - ACMA 2021,
  • SCOPE - WOF 2020

Timeline

Field Medical Advisor - Cardiometabolic

Novo Nordisk Saudi Arabia
06.2025 - Current

Sr. Metabolic Regional Medical Advisor

Novo Nordisk
04.2019 - 05.2025

Sr. Medical Representative

Novo Nordisk
07.2013 - 03.2019

Advanced Medical Representative

Novartis Pharmaceuticals
07.2011 - 06.2013

Master of Science - Health Economics

Pompeu De Fabra University

Bachelor of Science - Pharmaceutical Sciences

Helwan University
Ahmed Ashmawy